$ABT
Abbott Laboratories
XNYS•Health Care•Pharmaceutical Preparations
Why is ABT up today? It is at $105.85 (+0.13%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABT spikes, and full due diligence on ABT — key stats, earnings, dilution and insider activity. Free.
Get free $ABT alerts the moment volume spikes
Our scanner flagged $ABT 17 times in the last 30 days. Create a free account to track $ABT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $105.85
- Change today
- +0.13%
- Previous close
- $105.71
- 52-week range
- $81.97 – $137.49
- Market cap
- $184.13B
- Dividend yield
- 2.38% ($2.52)
- Shares outstanding
- 1.74B
- Institutional own.
- 91.46%
- Total held
- 92.0%
- Tradeable float
- 140.1M 8% of shares · after <1% insiders + 91% institutions
- Short interest
- 24.8M ▲ +6% vs prior · as of 2026-07-15
- Short % of float
- 17.7%
- Days to cover
- 2.1d
- Avg daily volume
- 9.7M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNYS
- 5m
- 1.0x
- 15m
- 0.9x
- 1h
- 0.8x
- 1D
- 0.0x
Get free ABT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ABT moving today?
ABT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ABT today, peaking at 2.0x its normal volume.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
2 open-market buys0 buys, 2 sells last 3 months (30/23 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Morrone Louis H. Officer | Sold (automatic/other) | -269 | sold 0.4% | 77K | $25K at $92.71 | Jun 30, 26 |
Cushman Elizabeth C. Officer | Sold (automatic/other) | -560 | sold 1.5% | 38K | $53K at $94.12 | Jun 27, 26 |
Stratton John G Director | Bought (open market) | +2K | added 9.4% | 23K | $174K at $86.82 | May 7, 26 |
Moreland Mary K Officer | Acquired (grant/award) | +5K | added 45% | 17K | $502K at $94.41 | Apr 28, 26 |
Starks Daniel J Director | Bought (open market) | +10K | added 0.1% | 6.75M | $927K at $92.65 | Apr 27, 26 |
Ahuja Nita Director | Acquired (grant/award) | +2K | n/a | 2K | n/a | Apr 24, 26 |
Babineaux-Fontenot Claire Director | Acquired (grant/award) | +2K | added 43% | 8K | n/a | Apr 24, 26 |
Blount Sally E. Director | Acquired (grant/award) | +2K | added 6.7% | 36K | n/a | Apr 24, 26 |
Gonzalez Patricia Paola Director | Acquired (grant/award) | +2K | added 33% | 9K | n/a | Apr 24, 26 |
Kumbier Michelle Director | Acquired (grant/award) | +2K | added 15% | 18K | n/a | Apr 24, 26 |
Mcdew Darren W Director | Acquired (grant/award) | +2K | added 22% | 13K | n/a | Apr 24, 26 |
Mckinstry Nancy Director | Acquired (grant/award) | +2K | added 5.9% | 41K | n/a | Apr 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $ABT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ABT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ABT Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.





Stocks similar to ABT
Comparable names in pharmaceutical preparations, closest in size first.
ABT is in these themes
Curated groups ABT belongs to. Tap one to see every member with today's move and why the group is moving.
ABT stock FAQ
Why is $ABT moving today?
ABT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ABT today, peaking at 2.0x its normal volume.
What is the ABT stock price today?
ABT last traded at $105.85, up 0.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does ABT pay a dividend?
Yes. ABT currently has a dividend yield of about 2.38% ($2.52 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live ABT alerts?
The ABT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABT 17 times in the last 30 days.
What exchange is ABT on?
ABT (Abbott Laboratories) trades on XNYS, with a market cap of about $184.13B in the PHARMACEUTICAL PREPARATIONS sector.
Is ABT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.